Skip to main content
. 2018 Sep 27;9(10):1009. doi: 10.1038/s41419-018-1030-y

Fig. 5. The function variation of CRC cells as AKT was inhibited by Afuresertib.

Fig. 5

a Western blot analysis showed AKT inhibitor Afuresertib inhibited the activation of AKT pathway induced by KRT80, and variation of EMT markers in CRC cells. b, c Afuresertib inhibited migration and invasion of CRC cells. d IF staining showed the expression of Vimentin and E-Cadherin after Afuresertib was used